Latest Articles
NHS is 'neglecting women' as thousands are left to languish on waiting lists for years - Daily Mail
NHS is 'neglecting women' as thousands are left to languish on waiting lists for years Daily Mail
Published: April 19, 2025, 6:28 p.m.
Sky Sports presenter shares health update after surgery and 'heartbreaking' condition - Daily Express
Sky Sports presenter shares health update after surgery and 'heartbreaking' condition Daily Express
Published: April 19, 2025, 10:59 a.m.
Reproductive endocrinology and fertility fellowship with UW Health expands access to care - WIFR
Reproductive endocrinology and fertility fellowship with UW Health expands access to care WIFR
Published: April 19, 2025, 1:52 a.m.
‘It’s a disaster’: Trans woman who claimed her breastmilk can ‘benefit’ babies feels ‘sexless’ after Supreme Court ruling - MSN
‘It’s a disaster’: Trans woman who claimed her breastmilk can ‘benefit’ babies feels ‘sexless’ after Supreme Court ruling MSN
Published: April 19, 2025, 1:26 a.m.
Pearsanta to begin study of endometriosis test with IRB approval - MSN
Pearsanta to begin study of endometriosis test with IRB approval MSN
Published: April 19, 2025, 1:06 a.m.
The First Endometriosis Surgeries Were Successfully Performed In Hospital Azar - EIN News
The First Endometriosis Surgeries Were Successfully Performed In Hospital Azar EIN News
Published: April 18, 2025, 9:33 p.m.
Samantha Ruth Prabhu’s latest podcast is all about breaking taboo - Moneycontrol
Samantha Ruth Prabhu’s latest podcast is all about breaking taboo Moneycontrol
Published: April 18, 2025, 7:30 p.m.
9,000 Pro-Life Businesses No Longer Forced to Fund Abortions - lifenews.com
9,000 Pro-Life Businesses No Longer Forced to Fund Abortions lifenews.com
Published: April 18, 2025, 5:33 p.m.
More women welcome AI assistance for mammography exams - AuntMinnie
More women welcome AI assistance for mammography exams AuntMinnie
Published: April 18, 2025, 4:49 p.m.
Dostarlimab/Chemo Earns Expanded Canadian Approval in Primary Advanced, First Recurrent Endometrial Cancer - OncLive
Dostarlimab/Chemo Earns Expanded Canadian Approval in Primary Advanced, First Recurrent Endometrial Cancer OncLive
Published: April 18, 2025, 3:54 p.m.
Link copied to clipboard!